IBDEI19M ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21159,1,4,0)
 ;;=4^I69.193
 ;;^UTILITY(U,$J,358.3,21159,2)
 ;;=^5007455
 ;;^UTILITY(U,$J,358.3,21160,0)
 ;;=I69.293^^101^1027^16
 ;;^UTILITY(U,$J,358.3,21160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21160,1,3,0)
 ;;=3^Ataxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,21160,1,4,0)
 ;;=4^I69.293
 ;;^UTILITY(U,$J,358.3,21160,2)
 ;;=^5007487
 ;;^UTILITY(U,$J,358.3,21161,0)
 ;;=I69.093^^101^1027^14
 ;;^UTILITY(U,$J,358.3,21161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21161,1,3,0)
 ;;=3^Ataxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,21161,1,4,0)
 ;;=4^I69.093
 ;;^UTILITY(U,$J,358.3,21161,2)
 ;;=^5007423
 ;;^UTILITY(U,$J,358.3,21162,0)
 ;;=I69.893^^101^1027^15
 ;;^UTILITY(U,$J,358.3,21162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21162,1,3,0)
 ;;=3^Ataxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,21162,1,4,0)
 ;;=4^I69.893
 ;;^UTILITY(U,$J,358.3,21162,2)
 ;;=^5007549
 ;;^UTILITY(U,$J,358.3,21163,0)
 ;;=I69.31^^101^1027^17
 ;;^UTILITY(U,$J,358.3,21163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21163,1,3,0)
 ;;=3^Cognitive deficits following cerebral infarction
 ;;^UTILITY(U,$J,358.3,21163,1,4,0)
 ;;=4^I69.31
 ;;^UTILITY(U,$J,358.3,21163,2)
 ;;=^5007490
 ;;^UTILITY(U,$J,358.3,21164,0)
 ;;=I69.11^^101^1027^18
 ;;^UTILITY(U,$J,358.3,21164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21164,1,3,0)
 ;;=3^Cognitive deficits following nontraumatic intcrbl hemorrhage
 ;;^UTILITY(U,$J,358.3,21164,1,4,0)
 ;;=4^I69.11
 ;;^UTILITY(U,$J,358.3,21164,2)
 ;;=^5007426
 ;;^UTILITY(U,$J,358.3,21165,0)
 ;;=I69.01^^101^1027^19
 ;;^UTILITY(U,$J,358.3,21165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21165,1,3,0)
 ;;=3^Cognitive deficits following ntrm subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,21165,1,4,0)
 ;;=4^I69.01
 ;;^UTILITY(U,$J,358.3,21165,2)
 ;;=^5007394
 ;;^UTILITY(U,$J,358.3,21166,0)
 ;;=I69.81^^101^1027^21
 ;;^UTILITY(U,$J,358.3,21166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21166,1,3,0)
 ;;=3^Cognitive deficits following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,21166,1,4,0)
 ;;=4^I69.81
 ;;^UTILITY(U,$J,358.3,21166,2)
 ;;=^5007521
 ;;^UTILITY(U,$J,358.3,21167,0)
 ;;=I69.21^^101^1027^20
 ;;^UTILITY(U,$J,358.3,21167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21167,1,3,0)
 ;;=3^Cognitive deficits following oth ntrm intcrn hemorrhage
 ;;^UTILITY(U,$J,358.3,21167,1,4,0)
 ;;=4^I69.21
 ;;^UTILITY(U,$J,358.3,21167,2)
 ;;=^5007458
 ;;^UTILITY(U,$J,358.3,21168,0)
 ;;=I69.391^^101^1027^22
 ;;^UTILITY(U,$J,358.3,21168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21168,1,3,0)
 ;;=3^Dysphagia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,21168,1,4,0)
 ;;=4^I69.391
 ;;^UTILITY(U,$J,358.3,21168,2)
 ;;=^5007516
 ;;^UTILITY(U,$J,358.3,21169,0)
 ;;=I69.191^^101^1027^23
 ;;^UTILITY(U,$J,358.3,21169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21169,1,3,0)
 ;;=3^Dysphagia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,21169,1,4,0)
 ;;=4^I69.191
 ;;^UTILITY(U,$J,358.3,21169,2)
 ;;=^5007453
 ;;^UTILITY(U,$J,358.3,21170,0)
 ;;=I69.291^^101^1027^25
 ;;^UTILITY(U,$J,358.3,21170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21170,1,3,0)
 ;;=3^Dysphagia following oth nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,21170,1,4,0)
 ;;=4^I69.291
 ;;^UTILITY(U,$J,358.3,21170,2)
 ;;=^5007485
 ;;^UTILITY(U,$J,358.3,21171,0)
 ;;=I69.091^^101^1027^24
 ;;^UTILITY(U,$J,358.3,21171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21171,1,3,0)
 ;;=3^Dysphagia following nontraumatic subarachnoid hemorrhage
